Literature DB >> 22135791

Control of blood pressure in chronic kidney disease: how low to go?

Anadil Faqah1, Tazeen H Jafar.   

Abstract

Blood pressure (BP) lowering is an important therapeutic goal in patients with diabetic and non-diabetic chronic kidney disease (CKD) for slowing progression and preventing onset of cardiovascular disease. The guidelines for treatment of hypertension in patients with CKD recommend a target BP <130/80 mm Hg, with no clear threshold on the lower limit. However, results of recent randomized controlled trials on CKD indicate that aggressive lowering of BP may not provide additional benefit in the vast majority of patients. This paper will review the literature on the main trials examining the question concerning the optimal level of target BP in patients with CKD and also discuss reasonable target BP levels in light of the evidence, as well as future direction for research in such patients.
© 2011 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22135791     DOI: 10.1159/000331066

Source DB:  PubMed          Journal:  Nephron Clin Pract        ISSN: 1660-2110


  2 in total

1.  Multicomponent intervention versus usual care for management of hypertension in rural Bangladesh, Pakistan and Sri Lanka: study protocol for a cluster randomized controlled trial.

Authors:  Tazeen H Jafar; Imtiaz Jehan; H Asita de Silva; Aliya Naheed; Mihir Gandhi; Pryseley Assam; Eric A Finkelstein; Helena Legido Quigley; Marcel Bilger; Aamir Hameed Khan; John David Clemens; Shah Ebrahim; Elizabeth L Turner; Anuradhani Kasturiratne
Journal:  Trials       Date:  2017-06-12       Impact factor: 2.279

Review 2.  Aryl Hydrocarbon Receptor Mechanisms Affecting Chronic Kidney Disease.

Authors:  Colleen S Curran; Jeffrey B Kopp
Journal:  Front Pharmacol       Date:  2022-02-14       Impact factor: 5.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.